Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes (RBC) was studied in vitro before and during culture by measuring the chloroquine gradient between the cells and medium (C/M) by high-pressure liquid chromatography. The C/M values were 5.9 ± 2.7 (n = 23) for uninfected RBC, 13 to 34 for six chloroquine-susceptible isolates (concentration required to inhibit 50% of parasite growth, <100 nmol/liter) in partially infected RBC (parasitemia from 0.3 to 5%) (n = 28), and 8.4 to 4.9 for four chloroquine-resistant isolates (concentration required to inhibit 50% of parasite growth, 320 to 1,500 nmol/liter) in partially infected RBC (parasitemia from 0.4 to 5%) (n = 26). Two isolates were studied before and after adaptation to continuous culture. C/M was found to decrease (34.2 to 2.1 and 19.3 to 4.9), whereas the concentration required to inhibit 50% of parasite growth increased (35 to 1,400 and 54 to 1,500 nmol/liter), thus indicating the acquisition of chloroquine resistance. These results demonstrate that chloroquine uptake decreased in RBC in which the infective strain, initially susceptible, became resistant in culture and imply that the drug is bound to ferriprotoporphyrin IX to a lesser extent or that a parasite protein competes with ferriprotoporphyrin IX to a greater extent. We suggest that genotypic modifications in the mechanism of chloroquine uptake might occur in the parasite.
The rapid activity of antimalarial drugs is related to their high binding capacity to infected erythrocytes (RBC). The high accumulation of chloroquine in Plasmodium berghei-infected RBC was first demonstrated by Macomber (14) . This was confirmed by Fitch (4) , who showed that the accumulation was decreased when the P. berghei strains were chloroquine resistant. Later, Fitch confirmed the decrease in chloroquine uptake by Aotus trivirgatus RBC infected with chloroquine-resistant Plasmodium falciparum (5) .
The difference in chloroquine uptake might be due to lower penetration across infected membranes of RBC (variations in permeability), a difference in binding to the intraerythrocytic receptor ferriprotoporphyrin IX (FP), to which chloroquine is bound with high affinity (3, 8) , or both.
In our laboratory, we maintain long-term continuous cultures of P. falciparum strains isolated from humans. We have shown that initially chloroquine-susceptible P. falciparum isolates become resistant after adaptation to culture (13) . The next step was to study chloroquine uptake by RBC infected with a P. falciparum strain when it was initially chloroquine susceptible and when it became chloroquine resistant after adaptation to culture. This was the aim of the present work.
MATERIALS AND METHODS
Eight uncloned P. falciparum isolates were obtained from malarial patients treated at Claude Bernard Hospital in Paris. Six isolates from West Africa were susceptible to chloroquine in vivo and in vitro as shown by the concentration required to inhibit 50% of parasite growth (IC50) of less than 100 nmol/liter (12) . The other two isolates (from patients * Corresponding author.
from Thailand and Tanzania) were resistant to chloroquine in vivo and in vitro (IC50, 670 and 320 nmol/liter, respectively).
Isolates (uncultured specimens) were identified by a chronological number for each patient; strains (cultured for over 5 weeks) were identified by FCM (for falciparum) and a chronological number, also. Both identifications were followed by the country of origin.
The isolates were cultivated in RPMI 1640 with 25 mmol of NaHCO3 per liter, 25 mmol of HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) per liter, and 10% pooled normal fresh human serum in an atmosphere of 5% 02-6% CO2-89% N2 by the petri dish method of Trager and Jensen. The details are described elsewhere (11) .
A 5% suspension of infected RBC (0.7 ml) was incubated in 16-mm-diameter wells with the drug. Chloroquine concentrations varied from 100 to 4,000 nmol/liter. The contact time between chloroquine and the suspension of RBC was 28 and 47 h at 37°C.
After incubation, RBC were removed from the supernatant by centrifuging at 2,000 x g for 15 min without washing to avoid chloroquine extraction. The two fractions, cells (C) and medium (M), were frozen in plastic tubes at -30°C until the chloroquine assay was done. The fractions were then thawed, diluted in distilled water, sonicated, and alkalinized with 1 N NaOH. Chloroquine was assayed by high-pressure liquid chromatography (HPLC) after extraction by dichloromethane at pH 11 (18) . The organic phase was then reextracted with 0.1 N HCI, and the hydrochloric extract was injected on a ,uBondapak C18 reversed-phase column.
The UV absorbance was detected at 254 nm.
Standard chloroquine curves were plotted for normal RBC and for culture medium. The RBC were lysed and diluted as described above. We carried out two control tests to ensure that all of the chloroquine had been recovered from RBC after extraction.
(i) A sample of RBC was overloaded with 1,000 nmol of chloroquine per liter. The chloroquine was measured by HPLC as described above after incubation at 37°C for 1 h, with shaking every 10 min.
(ii) We compared the chloroquine concentration gradient (C/M) determined by HPLC with that determined by a radioisotopic method with [3H]chloroquine (2, The results of the control tests were as follows. (i) Chloroquine was recovered from the RBC (n = 3) at a 100% rate (1,008 ± 21 nmol/liter). (ii) Chloroquine concentration gradients (C/M) obtained by HPLC and the radioisotopic method, expressed as the mean plus or minus standard deviation of measurements done on three wells, were as follows, respectively: 2.8 ± 0.4 and 2.3 ± 0.3 for uninfected RBC; and 2.9 ± 0.7 and 3.2 ± 0.3 for a culture in which 6.4% of RBC were infected with a chloroquine-resistant strain. In the group of chloroquine-susceptible P. falciparum, all IC50s were below 100 nmol/liter. The measurements were done within 2 days of blood collection, i.e., before beginning the culture (day 1). The C/M values varied between 13.4 and 34.2 for parasitemias from 0.3 to 5%, with chloroquine concentrations between 200 and 4,000 nmol/liter in the isolate from patient no. 1 (Tanzania) and two different concentrations (100 to 400 nmol/liter) for the other isolates or strains.
In the group of chloroquine-resistant P. falciparum, all
IC50s were above 100 nmollliter (320 to 1,500 nmollliter). The measurements were done after adaptation to culture (day 43 to 322), except for one which was done on an initially chloroquine-resistant isolate (day 1 
DISCUSSION
The results of the two control tests done to verify the chloroquine extraction from the RBC show that all of the drug is extracted with our method. The fact that chloroquine has a high affinity for its receptor (Kd = 10-8 M) (4) does not prevent total recovery of intracellular chloroquine under these conditions. Chloroquine uptake by RBC is known to be rapid (less than 30 min) (5). However, we chose contact times of 28 and 47 h (Table 1 ) to correspond to the in vitro activity tests. Thus, there was no significant difference between the C/M values for these contact times.
RBC infected with chloroquine-susceptible P. falciparum accumulate more chloroquine than RBC infected with chloroquine-resistant strains (Table 1 ). In addition, the evolution of a strain during the weeks of culture at a constant parasitemia level is indicated by the acquisition of chloroquine resistance (IC50 increase) and a decrease of chloroquine uptake to a level similar to that of uninfected RBC. The plasmodial behavior might be modified by the in vitro conditions; clonal selection might occur during culture. Despite this, the low C/M gradient in both infected RBC after long-term culture and RBC infected with a naturally chloroquine-resistant strain has demonstrated that chloroquine uptake is greater in chloroquine-susceptible strains than in resistant ones. This may involve the penetration of chloroquine across the membranes of the RBC, the biochemical pathways of the parasite itself, or both. Indeed, various alterations of infected membranes have been recently described by several authors. For example, the normal membrane, which is impermeable to substrates such as sorbitol, becomes permeable when infected (9); electron transport is modified (16, 17) ; the components of the surface membrane are altered (10); and the structure itself is modified (presence of knobs) (1) . However, the relationship between these modifications and chloroquine resistance is still not clearly understood.
The degradation of hemoglobin is a major source of amino acid for the parasite. This catabolism results in the formation (solid lines) before and after adaptation to in vitro culture. [Isolates from two P. falciparum strains with parasitemia of 0.4% for FCM18 (@) and 5% for FCM20 (U).] of the malarial pigment in which FP is trapped. On account of its soluble heme binders, the parasite forms a nontoxic complex with FP (2) which is then stored in its food vacuole. Chloroquine acts by diverting FP complexes with soluble parasitic products into a toxic FP-chloroquine complex which impairs the ability of the parasite and the host RBC to maintain cation gradients. The parasite dies because of the ionic changes or because of outright lysis (6) .
FP production is increased by the digestive processes of the parasite (19) . In a study on P. berghei, Mahoney and Eaton (15) showed that chloroquine-susceptible and -resistant strains had different capacities of degrading hemoglobin (i.e., producing FP). They related this phenomenon to a modification in protease activity. In recent work, however, Yayon et al. (20) demonstrated that both chloroquine-susceptible and -resistant strains of P. berghei digested hemoglobin and concluded that chloroquine resistance cannot be related to a lack of FP production. FP produced by chloroquine-resistant parasites is unable to bind chloroquine with high affinity. This might be due to an increase in the intra-erythrocytic heme binders of the parasite and an increase of the FP sequestration phenomenon (6, 7) .
In our work, the decrease of chloroquine uptake at low constant parasitemia levels by P. falciparum-infected human RBC during long-term culture (i.e., after the acquisition of chloroquine resistance) supports the hypothesis that FP produced by chloroquine-resistant parasites does not bind chloroquine to a great extent. In the P. berghei models, parasitemia was usually high (50 to 80%), lysis of infected and uninfected RBC was probably considerable, and the chloroquine fixation was partly extra-erythrocytic. In our P. falciparum model on human RBC, the low parasitemia was similar to that in malarial patients. The lysis of the RBC was very low, and the extracellular chloroquine fixation by oxidized derivatives of hemoglobin was unlikely.
The similar behavior regarding chloroquine uptake by human RBC, whether infected with a naturally resistant strain of P. falciparum or with an initially chloroquine-susceptible strain which became resistant without drug pressure during culture, might suggest that the parasite undergoes genotypic modifications. These results have encouraged us to compare the behavior of other amino-4-quinolines in relation to drug uptake. We are studying these questions in our current research.
